文献速递消化道肿瘤与早癌

整合宏基因组与代谢组学分析揭示早发性结直肠癌中独特的肠道微生物组衍生表型

Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer.
PubMed 文献 · Gut · 2022-08-11

该研究通过宏基因组与代谢组学分析,在发现队列(130例晚发性结直肠癌、114例早发性结直肠癌及年龄匹配健康对照97例晚发性对照和100例早发性对照)中鉴定多组学标志物并构建结直肠癌分类器,并在独立队列(38例晚发性结直肠癌、24例早发性结直肠癌、22例晚发性对照和24例早发性对照)中验证。研究发现早发性与晚发性结直肠癌具有不同的微生物组-代谢组关联,基于微生物组衍生标志物的预测模型对区分早发性结直肠癌与对照具有强大分类性能。

要点

  • 早发性与晚发性结直肠癌的微生物组-代谢组关联存在差异,多组学特征可区分两者。
  • 基于宏基因组、代谢组及KO基因标志物的预测模型对区分早发性结直肠癌与对照具有强大分类性能。
  • 红肉摄入相关菌种、胆碱代谢物及KO pldB和cbh基因轴可能是早发性结直肠癌的潜在肿瘤促进因素。

核心结论

  • 大样本多组学数据提示,改变的微生物组-代谢组相互作用有助于解释早发性结直肠癌和晚发性结直肠癌的发病机制。
  • 微生物组衍生标志物有潜力作为非侵入性工具,用于准确检测和区分早发性结直肠癌个体。

研究设计与样本

  • 研究进行宏基因组和代谢组学分析,鉴定多组学标志物并为发现队列构建结直肠癌分类器。
  • 发现队列包括130例晚发性结直肠癌、114例早发性结直肠癌受试者及年龄匹配健康对照(97例晚发性对照和100例早发性对照)。
  • 独立验证队列包括38例晚发性结直肠癌、24例早发性结直肠癌、22例晚发性对照和24例早发性对照。

主要发现

  • 与对照相比,晚发性结直肠癌和早发性结直肠癌受试者均表现出α多样性降低。
  • 尽管存在共同变异,整合分析在晚发性结直肠癌和早发性结直肠癌中鉴定出不同的微生物组-代谢组关联。
  • 晚发性结直肠癌的特征包括具核梭杆菌富集和短链脂肪酸耗竭,包括微生物GABA生物合成减少以及乙酸/乙醛代谢向乙酰辅酶A生成转变。
  • 早发性结直肠癌的多组学特征倾向于与Flavonifractor plauti富集及色氨酸、胆汁酸和胆碱代谢增加相关。
  • 红肉摄入相关菌种升高、胆碱代谢物及KEGG直系同源(KO)pldB和cbh基因轴可能是早发性结直肠癌的潜在肿瘤促进因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The incidence of early-onset colorectal cancer (EO-CRC) is steadily increasing. Here, we aimed to characterise the interactions between gut microbiome, metabolites and microbial enzymes in EO-CRC patients and evaluate their potential as non-invasive biomarkers for EO-CRC. DESIGN: We performed metagenomic and metabolomic analyses, identified multiomics markers and constructed CRC classifiers for the discovery cohort with 130 late-onset CRC (LO-CRC), 114 EO-CRC subjects and age-matched healthy controls (97 LO-Control and 100 EO-Control). An independent cohort of 38 LO-CRC, 24 EO-CRC, 22 LO-Controls and 24 EO-Controls was analysed to validate the results. RESULTS: Compared with controls, reduced alpha-diversity was apparent in both, LO-CRC and EO-CRC subjects. Although common variations existed, integrative analyses identified distinct microbiome-metabolome associations in LO-CRC and EO-CRC. Fusobacterium nucleatum enrichment and short-chain fatty acid depletion, including reduced microbial GABA biosynthesis and a shift in acetate/acetaldehyde metabolism towards acetyl-CoA production characterises LO-CRC. In comparison, multiomics signatures of EO-CRC tended to be associated with enriched Flavonifractor plauti and increased tryptophan, bile acid and choline metabolism. Notably, elevated red meat intake-related species, choline metabolites and KEGG orthology (KO) pldB and cbh gene axis may be potential tumour stimulators in EO-CRC. The predictive model based on metagenomic, metabolomic and KO gene markers achieved a powerful classification performance for distinguishing EO-CRC from controls. CONCLUSION: Our large-sample multiomics data suggest that altered microbiome-metabolome interplay helps explain the pathogenesis of EO-CRC and LO-CRC. The potential of microbiome-derived biomarkers as promising non-invasive tools could be used for the accurate detection and distinction of individuals with EO-CRC.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Kong C, Liang L, Liu G, et al. Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer. Gut. 2022. PMID: 35953094. doi:10.1136/gutjnl-2022-327156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。